Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Small-Molecule Structural Differences in IP Valuation Two Different Asset Classes Requiring Two Different Models A systematic comparison of biologic and small-molecule drug development and IP economics drawing on a 2024 analysis by Beall et al
Both belong to the same drug class but may show slightly different outcomes for patients
They have similar shapes but differ in sizes and current ratings
Furthermore, educating patients about the potential for dizziness as a side effect and strategies to mitigate it is crucial
Oxid Med Cell Longev 2019 , 1704650
They run the numbers to check it, and the numbers seem to confirm what they already suspected
US$ 21.12
US$ 24.21
US$ 29.96
US$ 26.36
US$ 29.54
